The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of a phase II trial with sacituzumab govitecan-hziy in patients with recurrent endometrial carcinoma overexpressing Trop-2.
 
Alessandro Santin
Consulting or Advisory Role - Merck; R-Pharm; Tesaro
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Merck (Inst); Puma Biotechnology (Inst); R-Pharm (Inst); Tesaro (Inst); Verastem (Inst)
 
Blair McNamara
No Relationships to Disclose
 
Eric R. Siegel
No Relationships to Disclose
 
Justin Harold
No Relationships to Disclose
 
Levent Mutlu
No Relationships to Disclose
 
Gary Altwerger
No Relationships to Disclose
 
Gloria S. Huang
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
 
Vaagn Andikyan
No Relationships to Disclose
 
Mitchell B. Clark
No Relationships to Disclose
 
Elena Ratner
No Relationships to Disclose
 
Masoud Azodi
No Relationships to Disclose
 
Peter Dottino
No Relationships to Disclose
 
Peter E. Schwartz
No Relationships to Disclose
 
Stefania Bellone
No Relationships to Disclose